# Pharmaceutical Care for Patients Using Capecitabine

> **NCT07063706** · NA · COMPLETED · sponsor: **Faculdade de Farmácia** · enrollment: 176 (actual)

## Conditions studied

- Cancer Colorectal
- Cancer Gi
- Capecitabine
- Pharmaceutical Services
- Adverse Drug Reaction (ADR)

## Interventions

- **OTHER:** Pharmaceutical Care

## Key facts

- **NCT ID:** NCT07063706
- **Lead sponsor:** Faculdade de Farmácia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-08-30
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063706, "Pharmaceutical Care for Patients Using Capecitabine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07063706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*